DRUG · Unmapped registry intervention
Chimeric receptor T-cells + Trastuzumab
Find medicine records ·
Find other trials using this name
Clinical trial
Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors
NCT06027983
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Fludarabine and Cyclophosphosphamide
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedChimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HER2+ Advanced Breast Cancerunresolved
Other Solid Tumorsunresolved
Interventions
Sponsors & collaborators
National University Hospital, Singaporelead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06027983 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.